mir-542-5p在浆液性卵巢癌中的表达及其作用机制的研究

《mir-542-5p在浆液性卵巢癌中的表达及其作用机制的研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、分类号R711UDC618密级公开miR-542-5p在浆液性卵巢癌中的表达及其作用机制的研究陈琳培养类别非全日制学位类型学术学位一级学科(专业类)临床医学二级学科(专业)妇产科学研究方向卵巢肿瘤的分子机制指导教师李艳红副教授（副主任医师）培养单位唐都医院妇产科二O一五年五月第四军医大学硕士学位论文目录缩略语表······························································································1中文摘要···

2、···························································································2英文摘要······························································································5前言·································································

3、·····························9文献回顾·····························································································10正文·····························································································19第一部分miR-542-5p在浆液性卵巢癌中的表达及意义····

4、····························191材料···························································································192方法···························································································203结果·································

5、··························································234讨论···························································································25第二部分miR-542-5p对卵巢癌细胞SKOV3恶性生物学行为的影响的研究······281材料·····················································

6、······································282方法···························································································293结果···························································································324讨论·······················

7、····································································37第三部分miR-542-5p靶基因的预测和验证···············································391材料···························································································392方法·················

8、··········································································423结果···························································································474讨论···················